Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells.
Witowski J, Korybalska K, Ksiazek K, Wisniewska-Elnur J, Jörres A, Lage C, Schaub TP, Passlick-Deetjen J, Breborowicz A, Grzegorzewska A, Ksiazek A, Liberek T, Lichodziejewska-Niemierko M, Majdan M, Rutkowski B, Stompór T, Sulowicz W.
Witowski J, et al. Among authors: jorres a.
Nephrol Dial Transplant. 2004 Apr;19(4):917-24. doi: 10.1093/ndt/gfh013.
Nephrol Dial Transplant. 2004.
PMID: 15031350
Clinical Trial.